Back Bay Life Science Advisors
Market Insights
Investment Banking Analytics Strategic Advisory
Company Global Partnerships Meet Our Team Careers Resource Library Locations
DNB//Back Bay Partnership DNB//Back Bay Healthcare Team
Corporate Contact Toronto Office
OUR SERVICES Investment Banking Analytics Strategic Advisory About Company Global Partnerships Meet Our Team Careers Resource Library Locations Market Insights DNB//BACK BAY DNB//Back Bay Partnership DNB//Back Bay Healthcare Team Contact Corporate Contact Toronto Office
Back Bay Life Science Advisors

News and Events Archive


Back Bay on Bloomberg Baystate Business: Rare Disease Treatments
News, UncategorizedBack Bay Life Science AdvisorsMarch 10, 2019BIO Innovation, Biotech, Drug development, Rare diseases
Back Bay to Moderate MassBio BD/Finance Forum on Considerations for an Economic Downturn
Events, UncategorizedBack Bay Life Science AdvisorsMarch 4, 2019M&A, Transactions
Back Bay Sponsors DKBIO2019 Danish Science & the City
EventsJocelyn MillerFebruary 28, 2019Denmark, Drug development, Europe, Investment, Life Science Events
New White Paper: The Microbiome and Immuno-Oncology
Blog, Jonathan Barry Posts, Peter Bak Posts, WhitepapersBack Bay Life Science AdvisorsFebruary 25, 2019cancer treatment, Drug development, immuno-oncology, microbiome
Back Bay to Host Young Women in Bio and Boston University
EventsJocelyn MillerFebruary 14, 2019
Back Bay Life Science Advisors at HIMSS 2019
EventsJocelyn MillerFebruary 14, 2019
Xconomy: Gossamer Bio Turns Back from Alternative IPO Path
News, Back Bay in the Newsjonathan gertlerFebruary 4, 2019Biotech, IPO
Back Bay MedTech Experts at MD&M West
EventsJocelyn MillerJanuary 28, 2019
Boston Business Journal: Reverberations of the Shutdown Felt by MA Businesses
News, Back Bay in the NewsBack Bay Life Science AdvisorsJanuary 23, 2019BioPharma Development, Boston Life Science Ecosystem
Back Bay Life Science Advisors Sponsors MassBio Rare Disease Day
EventsJocelyn MillerJanuary 23, 2019Denmark, Europe, Life Science Events, Partnering
New White Paper: A Rare-Disease Approach to Seizure Treatment
Michelle Hoffmann Posts, Susan Thompson Posts, WhitepapersBack Bay Life Science AdvisorsDecember 18, 2018Biotech, Drug development, Epilepsy, Rare diseases, Seizure
Back Bay in STAT: Antibiotic Breakthroughs
News, Peter Bak Posts, Back Bay in the NewsBack Bay Life Science AdvisorsDecember 10, 2018Antibiotics, Anti-microbials, Drug development
Back Bay at the Nordic-American Life Science Conference, New York City
EventsBack Bay Life Science AdvisorsNovember 12, 2018Nordic, Emerging Biopharma, Emerging Medtech, Public companies, Investors, Conferences
Effective Strategy and Partnering Approaches For University-Generated IP
News, Whitepapers, Jonathan GertlerBack Bay Life Science AdvisorsOctober 17, 2018Tech Transger, Academic-Industry Partnering
Back Bay Life Science Advisors at BIO-Europe
EventsBack Bay Life Science AdvisorsOctober 10, 2018Denmark, Europe, Life Science Events, Partnering
Meet Back Bay Life Science Advisors at BioNetwork Partnering Summit 2018
Events, Industry EventsBack Bay Life Science AdvisorsSeptember 11, 2018
Back Bay Life Science Advisors on Campus
EventsBack Bay Life Science AdvisorsSeptember 5, 2018
Med Device Online: Examining Medtech's Booming Heart Valve Market
News, Back Bay in the NewsBack Bay Life Science AdvisorsAugust 22, 2018Heart Valve, MedDevice, Medical Device Manufacturers
Back Bay Life Science Advisors in the Boston Business Journal on Gene Therapy Regulation
Andrew Collard Posts, NewsBack Bay Life Science AdvisorsAugust 22, 2018Andrew Collard, Boston Business Journal
Back Bay in Pharmaceutical Executive: The State of Cross-Border Funding in the Life Sciences
NewsBack Bay Life Science AdvisorsAugust 9, 2018China, cross-border, funding, Life Science, private financing market
Newer Older
 

545 Boylston Street
12th Floor
Boston, MA 02116

+1 617.236.0954 Office
+1 617.236.1215 Fax

Boston | Toronto

 

OUR SERVICES


STRATEGIC ADVISORY >>

  • Life sciences corporate growth and market access strategy

  • Franchise, business unit & therapeutic area strategy

  • Competitive intelligence

  • Asset & development prioritization

  • Platform implementation

  • Payor/Pricing strategy

  • Contracting strategy

  • Launch & counter-launch strategy

  • Product positioning, branding & messaging

  • Life-cycle management

  • Corporate growth strategy

  • Liquidity & exit planning

INVESTMENT BANKING >>

FINANCING >>

  • Mergers, acquisitions & divestitures

  • IPO preparedness and execution

  • Private & public company, cross-border execution

  • Financing support

  • Fairness opinion, valuation

  • Treasury solutions

  • Fixed income origination

  • Equity and debt capital markets

  • Liquidity and exit planning

  • Due diligence and valuation

  • Divestments

  • Licensing (buy and sell side)

  • Partnering

  • Recapitalization

  • New Company formation

  • Investment Grade Bonds

  • High yield and convertible bonds

  • Debt and restructuring

Subscribe

Sign up with your email address to receive weekly market updates.

We respect your privacy.

Thank you for subscribing.


©2025 Back Bay Life Science Advisors | Privacy Policy